U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07419113) titled 'Development of an Integrated Multi-channel Artificial Nose for Cancer Detection (UNos)' on Feb. 03.

Brief Summary: Exhaled breath analysis using E-Nose sensors detects molecular fingerprints and shows promise for early cancer detection.

Study Start Date: Feb. 01, 2023

Study Type: INTERVENTIONAL

Condition: Head and Neck Cancer

Intervention: DEVICE: Artificial or Electronic Nose (E-Nose) medical device

medical device detecting breathe-out molecules

Recruitment Status: COMPLETED

Sponsor: Institute of Oncology Ljubljana

Disclaimer: Curated by HT Syndication....